DENTSPLY SIRONA(US:XRAY)2026-02-26 21:54Financial Performance - Net sales decreased by 3.0% compared to the prior year, with a constant currency decrease of 4.3% for the year ended December 31, 2025 [194]. - The net loss for the year was $598 million, an improvement from a net loss of $910 million in the prior year, with diluted loss per share of $3.00 compared to $4.48 [194]. - Cash flow from operations was $235 million, down from $461 million in the prior year [194]. - Total net sales decreased by 3.0% to $3,680 million in 2025 compared to $3,793 million in 2024, with a constant currency decrease of 4.3% [209]. - The Orthodontic and Implant Solutions segment saw a significant decline of 12.6% in net sales, primarily due to the suspension of Byte sales and lower volumes of implants [209][210]. - Connected Technology Solutions experienced a decrease in net sales of 2.5%, attributed to lower CAD/CAM product volumes in the United States, offset by higher imaging volumes in Europe and the Rest of World [209][211]. - Gross profit fell to $1,840 million in 2025, a decrease of 6.0% from $1,958 million in 2024, with gross profit as a percentage of net sales declining to 50.0% [215]. - Selling, general, and administrative expenses decreased by 10.4% to $1,438 million in 2025, down from $1,605 million in 2024 [217]. - Research and development expenses decreased by 9.0% to $150 million in 2025, compared to $165 million in 2024 [217]. - Goodwill and intangible asset impairments significantly decreased by 35.9% to $650 million in 2025 from $1,014 million in 2024 [217]. Product Development and Innovation - Dentsply Sirona launched several new products, including CEREC Primemill Lite and CEREC Go, aimed at enhancing digital workflows and improving patient care [42]. - Dentsply Sirona's innovative products are designed to support digital workflows, with a focus on enhancing patient care and operational efficiency in dental practices [20]. - Dentsply Sirona's product development strategy emphasizes continuous innovation, particularly in digital workflow solutions and cloud-based platforms like DS Core [39]. - The Company plans to increase its annual investment in research and development to approximately 5% of net sales beginning in 2026, up from the historical level of about 4% [41]. Market Presence and Competition - The Company maintains a strong market presence in approximately 140 countries, with significant operations in Europe and the Asia-Pacific region [18]. - The dental industry is expected to grow due to factors such as increasing demand for aesthetic dentistry and the rise of digital collaboration among dental professionals [34]. - The Company’s sales are generally strongest in the second and fourth quarters, influenced by seasonal factors and dental trade shows [73]. - The company faces competitive pressures in the dental industry, with potential impacts on product demand due to changes in customer preferences and economic conditions [102]. - The dental market is facing price competition due to the consolidation of practices and the rise of Dental Support Organizations, which may impact distributor relationships and sales [93]. Operational Challenges - The Company’s business is affected by macroeconomic conditions, including global supply chain constraints and interest rate variability, impacting manufacturing costs and product demand [73]. - The Company continues to face macroeconomic challenges, including inflation and supply chain constraints, affecting consumer confidence and discretionary spending [192]. - The implementation of a new global ERP system is ongoing, with significant capital investments made from 2023 to 2025, which may lead to higher costs and potential disruptions in sales and shipping activities [98]. - The company relies on a limited number of distributors for a substantial portion of its revenue, and efforts are being made to diversify this distributor base starting in 2026 [92]. - The company relies on a limited number of suppliers for certain raw materials, which could lead to supply chain disruptions and increased costs if those suppliers face issues [104]. - The impact of tariffs and trade policies remains uncertain, with ongoing evaluations to mitigate potential costs and supply chain disruptions [195]. Regulatory and Legal Risks - The Company is subject to various domestic and foreign laws regarding data privacy, including the GDPR and HIPAA, which mandate strict compliance measures [53]. - The company is exposed to legal and regulatory risks associated with the use of AI technologies, which may lead to additional operational costs and potential liabilities [86]. - The company is subject to extensive regulations, including the FDA and EU MDR, which may delay product approvals and market entry [130][134]. - The company is currently under a German tax investigation related to intercompany loans from 2016 and 2017, which could have a material impact on its financial condition [139]. - Changes in tax laws, including the OECD's global corporate minimum tax rate of 15%, could significantly affect the company's effective tax rate and financial position [143]. - Compliance with numerous applicable laws could result in substantial regulatory costs and potential enforcement actions, adversely affecting the company's financial performance [151]. Employee and Organizational Development - As of December 31, 2025, the Company employed approximately 14,000 employees globally, with about 3,000 in the United States [58]. - The Company’s total rewards strategy includes competitive compensation and benefits to attract and retain top talent, supporting employees' financial, physical, and mental well-being [70]. - The Company has nine Employee Resource Groups with approximately 4,700 members globally, fostering an inclusive environment [67]. - The Company’s global Employee Health & Safety program aligns with OHSAS 18001 and ISO 45001 standards to ensure employee safety [71]. - Talent gaps and challenges in retaining skilled employees may affect the company's ability to execute strategic initiatives and maintain competitive positioning [159]. Cybersecurity and Risk Management - The company has implemented new controls and procedures in response to past cyber incidents, but risks remain regarding potential future breaches and their financial implications [79]. - The company maintains a comprehensive cybersecurity risk management program, including annual training and assessments, to mitigate risks from cybersecurity threats [163][164]. - The Chief Information Security Officer (CISO) oversees cybersecurity strategies and reports to the Board of Directors quarterly on cybersecurity initiatives and incidents [171]. - The company has not experienced any material information security breaches in the last three years, but future risks remain [169]. - The company has made significant investments in information technology risk management and disaster recovery plans, but these measures may not fully protect against future cyber incidents [79]. Strategic Initiatives and Future Outlook - The company expects to incur non-recurring charges between $55 million to $65 million in connection with the 2026 restructuring plan, which aims to achieve approximately $120 million in annualized cost savings [97]. - The Company approved an increase to the authorized share repurchase program of $1.0 billion, with $1.2 billion remaining under this program as of December 31, 2025 [181]. - The Company entered into new non-exclusive distribution agreements with Patterson Dental Holdings to enhance growth and innovation in the dental equipment market [191]. - The company is focused on maximizing operational excellence and has undertaken process improvement initiatives to enhance global efficiency [202]. - The company is actively monitoring the impacts of geopolitical conflicts, such as the Russia-Ukraine conflict, which could lead to market disruptions and increased costs [126].